Quarterly report pursuant to Section 13 or 15(d)

9. Segment and Geographic Information

v3.10.0.1
9. Segment and Geographic Information
 9 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Segment and Geographic Information

Note 9. Segment and Geographic Information

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers. Additionally, the Company provides technical services to Invekra.

 

The following table presents the Company’s disaggregated product revenues by geographic region:

 

   

Three Months Ended

December 31,

    

Nine Months Ended

December 31,

  
    2018     2017     2018     2017  
United States   $ 2,977,000     $ 2,883,000     $ 7,374,000     $ 7,010,000  
Latin America     929,000       772,000       3,005,000       2,095,000  
Europe and Rest of the World     1,139,000       992,000       3,396,000       3,289,000  
Total   $ 5,045,000     $ 4,647,000     $ 13,775,000     $ 12,394,000  

 

The Company’s service revenues amounted to $235,000 and $196,000 for the three months ended December 31, 2018 and 2017, respectively. During the three months ended December 31, 2018 and 2017, the Company recorded service revenue related to technical services provided to Invekra in the amount of $14,000 in each period.

 

The Company’s service revenues amounted to $813,000 and $609,000 for the nine months ended December 31, 2018 and 2017, respectively. During the nine months ended December 31, 2018 and 2017, the Company recorded service revenue related to technical services provided to Invekra in the amount of $42,000 and $39,000, respectively.